Gonadotropin-Releasing Hormone Antagonist
Showing 1 - 25 of 7,634
Ovary Cyst, Fertility Issues Trial in Zagazig (progestin primed ovarian stimulation protocol, dydrogesterone (Duphaston,
Recruiting
- Ovary Cyst
- Fertility Issues
- progestin primed ovarian stimulation protocol
- +2 more
-
Zagazig, EgyptZagazig University
Mar 1, 2023
Diminished Ovarian Reserve Trial (Dydrogesterone priming ovarian stiumulation protocol, GnRH antagonist protocol)
Not yet recruiting
- Diminished Ovarian Reserve
- Dydrogesterone priming ovarian stiumulation protocol
- GnRH antagonist protocol
- (no location specified)
Apr 26, 2023
Infertility Trial in Istanbul (Gonadotropin releasing hormone antagonist (Cetrotide), Medroxyprogesterone Acetate (Tarlusal),
Not yet recruiting
- Infertility
- Gonadotropin releasing hormone antagonist (Cetrotide)
- +2 more
-
Istanbul, TurkeyBezmialem Vakif University
Mar 13, 2023
Prostate Cancer Metastatic, Radiation Therapy, Positron-Emission Tomography Trial in Umeå, Jönköping (stereotactic body
Recruiting
- Prostate Cancer Metastatic
- +2 more
- stereotactic body radiotherapy
- +2 more
-
Umeå, Umea, Sweden
- +1 more
May 19, 2022
Hypogonadism Trial in Denver (Acyline, Placebo Gel, Placebo Tablet)
Recruiting
- Hypogonadism
- Acyline
- +4 more
-
Denver, ColoradoUniversity of Colorado CCTSI CTRC
Apr 25, 2022
Infertility Trial in Xi'an (Biosimilar cetrorelix acetate, Reference cetrorelix acetate)
Not yet recruiting
- Infertility
- Biosimilar cetrorelix acetate
- Reference cetrorelix acetate
-
Xi'an, None Selected, ChinaHe Cai
Sep 7, 2023
Female Infertility Trial in Alexandria (gonadotropin releasing hormone-agonist, Progesterone)
Recruiting
- Female Infertility
- gonadotropin releasing hormone-agonist
- Progesterone
-
Alexandria, EgyptAlexandria University
Apr 5, 2022
Infertility, IVF, Preimplantation Diagnosis Trial in Barcelona (GnRh antagonist, Micronized progesterone)
Recruiting
- Infertility
- +2 more
- GnRh antagonist
- Micronized progesterone
-
Barcelona, Catalunya, SpainInstitut Universitari Dexeus
Mar 29, 2022
Preimplantation Genetic Testing, Progestin-primed Ovarian Stimulation, Polycystic Ovarian Syndrome Trial (GnRH antagonist, MPA)
Not yet recruiting
- Preimplantation Genetic Testing
- +3 more
- GnRH antagonist
- MPA
- (no location specified)
Apr 9, 2022
Ovarian Reserve, Poor Responders, IVF Trial in Gent (A single Gonadotropin-Releasing Hormone (GnRH) antagonist corifollitropin
Recruiting
- Ovarian Reserve
- +2 more
- A single Gonadotropin-Releasing Hormone (GnRH) antagonist corifollitropin alfa (CFA) stimulation
- Up to three modified natural cycles with Follitropin beta.
-
Gent, BelgiumUniversity Hospital Ghent
Mar 25, 2022
Central Precocious Puberty Trial (Debio 4326)
Not yet recruiting
- Central Precocious Puberty
- Debio 4326
- (no location specified)
Nov 8, 2023
Infertility Trial in Cairo, Giza (GnRH ant/letrozole, GnRH ant)
Unknown status
- Infertility
- GnRH ant/letrozole
- GnRH ant
-
Cairo, Egypt
- +1 more
Feb 12, 2020
Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility Trial (ultrashort GnRHa, short GnRHa, long GnRHa)
Not yet recruiting
- Intracytoplasmic Sperm Injection
- +3 more
- ultrashort GnRHa
- +2 more
- (no location specified)
Oct 2, 2022
Reproductive Disorder Trial in Boston (kisspeptin 112-121, GnRH)
Enrolling by invitation
- Reproductive Disorder
- kisspeptin 112-121
- GnRH
-
Boston, MassachusettsMassachusetts General Hospital
Jun 12, 2023
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,
Completed
- Prostate Adenocarcinoma
- +4 more
- Abiraterone Acetate
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022
Infertility Trial in Krasnodar (Gonadotropin-releasing hormone agonist)
Active, not recruiting
- Infertility
- Gonadotropin-releasing hormone agonist
-
Krasnodar, Krasnodar Krai, Russian FederationAlisa Baklakova
Nov 20, 2021
Prostatic Tumors Trial in Bronx (Abiraterone Acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Abiraterone Acetate
- Prednisone
-
Bronx, New YorkMontefiore Medical Center
Sep 22, 2022
Gonadotropin-releasing Hormone Agonist in Ovarian Preservation
Recruiting
- Systemic Lupus Erythematosus (Sle)
- Primary Ovarian Insufficiency (Poi)
-
Bethesda, MarylandNational Institute of Arthritis and Musculoskeletal and Skin Dis
Feb 2, 2023
Endometrial Tumor Malignant Stage I Trial in Shanghai (Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG,
Recruiting
- Endometrial Neoplasm Malignant Stage I
- Megestrol Acetate 160 MG Oral Tablet
- +3 more
-
Shanghai, Shanghai, China, ChinaObstetrics and Gynecology Hospital, Fudan University
Mar 25, 2022
Kallmann Syndrome, Idiopathic Hypogonadotropic Hypogonadism, GnRH Deficiency Trial in Boston (gonadotropin releasing hormone
Completed
- Kallmann Syndrome
- +2 more
- gonadotropin releasing hormone (GnRH)
-
Boston, MassachusettsMassachusetts General Hospital
Jun 29, 2022
Submucous Leiomyoma of Uterus Trial in Hangzhou (Zoladex, Mifepristone Oral Tablet)
Not yet recruiting
- Submucous Leiomyoma of Uterus
- Zoladex
- Mifepristone Oral Tablet
-
Hangzhou, Zhejiang, ChinaWomen's Hospital School of Medicine Zhejiang University
Jun 7, 2023
Reproductive Disorder, PCOS, Polycystic Ovary Syndrome Trial in Boston (kisspeptin 112-121, GnRH)
Not yet recruiting
- Reproductive Disorder
- +2 more
- kisspeptin 112-121
- GnRH
-
Boston, MassachusettsMassachusetts General Hospital
Jul 31, 2023
(Dyadic Adjustment) on Quality of Life of Prostate Cancer With
Completed
- Prostate Cancer
- Gonadotropin-releasing Hormone (GnRH) agonist therapy
-
Paris, FranceIpsen Central Contact
Dec 3, 2021
Ovarian Stimulation Trial in Shibin Al Kawm (Letrozole 2.5mg tablet)
Recruiting
- Ovarian Stimulation
- Letrozole 2.5mg tablet
-
Shibīn Al Kawm, Menoufia, EgyptMenoufia University hospital
Dec 8, 2021